Where Will Cara Therapeutics (CARA) Be in 5 Years?
It’s hard to forecast exactly how a specific stock will perform over just a 12-month period, let alone over five years. This is especially true for smaller biotech stocks, where
Read more »Why is Innovative Industrial Properties (IIPR) Trading Up 10% in the Past Week?
Innovative Industrial Properties (IIPR) has started off 2020 with another capital raise as they look to continue to grow their already impressive portfolio of cannabis-related real estate. The company announced
Read more »Why Canopy Growth Stock Popped 11% Yesterday
After tumbling nearly 5% in Monday trading, shares of Canadian cannabis company Canopy Growth (NYSE:CGC) rebounded Tuesday, closing the day up 11%…
Read more »Medipharm Labs Sues HEXO for Breach of Contract
A disagreement between two Canadian cannabis companies is headed to court. Medipharm Labs (OTC:MEDIF) said in a tersely worded press release Friday that one of its subsidiaries has filed a legal claim against
Read more »Is Aurora Cannabis the Titanic of Marijuana Stocks?
Comparing any stock to a ship probably isn’t the best analogy. However, I couldn’t help thinking of the Titanic after seeing some of the headlines over the last couple of months about Aurora
Read more »Will Cronos Group Rebound In 2020?
Cronos Group (NASDAQ:CRON) was once known as the best-performing marijuana stock of all time, and the good news for the company is that it performed better than many of its peers in 2019.
Read more »2020 May Be the Year Cannabis Stocks Surge Like Apple
Why go for overbought FAANG stocks that have limited upside when you can buy a badly beaten cannabis industry that’s ripe for bottom-picking? After a strong start in 2019, the
Read more »Aurora Cannabis (ACB): Love It or Leave It?
It’s one of the most controversial names in the cannabis industry. Aurora Cannabis (NYSE:ACB) definitely has its fair share of detractors. But some think that Aurora could be one of the biggest
Read more »1 Major Problem for the Cannabis Industry
There’s a lot of controversy surrounding the effectiveness of cannabis. While many people will claim that it has helped treat conditions that no other drug could, there are also people
Read more »Is Aurora Cannabis a Buy at Under $2?
Aurora Cannabis’ (NYSE:ACB) stock has been sinking like a stone lately. To put into perspective its massive decline: Troubled pot stock CannTrust Holdings is down 59% over the past six months. Aurora, however, has
Read more »